Cold Tabs Drug Recalled for CGMP Manufacturing Deviations
ULTRAtab Laboratories is recalling 4-Component Cold Tabs in bulk containers due to Current Good Manufacturing Practice (CGMP) deviations. The affected product was distributed to three distributors.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as a Class II recall, and the source text does not report any illnesses, injuries, or adverse events. The hazard is a manufacturing process deviation rather than a specific safety defect with demonstrated harm. This is a precautionary recall based on process deviations.
Plain-English summary
ULTRAtab Laboratories, Inc. is recalling 4-Component Cold Tabs (containing Acetaminophen 325 mg, Guaifenesin 200 mg, Dextromethorphan HBr 15 mg, and Phenylephrine HCl 5 mg) in bulk container form. A total of 19,103,287 tablets are affected.
The recall is being issued due to Current Good Manufacturing Practice (CGMP) deviations in the manufacturing process. The bulk product was distributed to three distributors, who may have distributed the finished product further.
Affected lots are identified by product codes C107L (bulk lots 18G085, 19B061, 19F066, 19J068), C107LB (bulk lots 18J051, 18M079, 18M080, 19B017, 19B018, 19C001, 19C081, 19D056, 19D057), and C107LA (bulk lot 19F067). The firm initiated this recall voluntarily on January 26, 2022, and the recall was terminated on January 7, 2025.
Consumers should contact their healthcare provider or pharmacist if they have questions about this product.
The recalled product
- Product
- 4-Component Cold Tabs (Acetaminophen 325 mg, Guaifenesin 200 mg, Dextromethorphan HBr 15mg, Phenylephrine HCL 5mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-107-00
- Manufacturer
- ULTRAtab Laboratories, Inc.
- Affected units
- 19,103,287
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Product Code: C107L Bulk Lots: 18G085
- 19B061
- 19F066
- 19J068 Product Code: C107LB Bulk Lots: 18J051
- 18M079
- 18M080
- 19B017
- 19B018
- 19C001
- 19C081
- 19D056
- 19D057 Product C107LA: Bulk lots: 19F067
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 33 recalled by ULTRAtab Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 33 products in this recall →Related recalls
Same manufacturer · ULTRAtab Laboratories, Inc.
See all →- ModerateDBI Magnums Caffeine Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2022-02-16
- ModerateHPC Tablet Drug Recalled Due to CGMP Manufacturing Deviations
FDA (Drugs) · 2022-02-16
- ModerateMelatonin ER supplement recalled for manufacturing practice deviations
FDA (Food) · 2022-02-16
- ModerateDietary supplement melatonin recall due to manufacturing deviations
FDA (Food) · 2022-02-16
- Moderate
Same hazard · cgmp deviation
See all →- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateBaxter Recalls Clindamycin Phosphate Injection Due to CGMP Deviations
FDA (Drugs) · 2026-09-09